AUROBINDO PHARMA LTD. - 524804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2024 is enclosed.02-04-2024
02-04-2024
AUROBINDO PHARMA LTD. - 524804 - Intimation Of Commencement Of Commercial Production At Four Manufacturing Facilities
Intimation of commencement of commercial production at four manufacturing facilities including Penicillin G through Company''s wholly owned subsidiary companies31-03-2024
Aurobindo Pharma Arm Extends Negotiations Deadline With MSD For Contract Manufacturing Operations
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has extended the deadline for negotiations with Merck Sharp & Dohme Singapore for contract manufacturing operations for biologicals until May 2024.28-03-2024
AUROBINDO PHARMA LTD. - 524804 - Curateq Agreed With MSD To Extend The Timelines Of LOI Till 31St May 2024
Intimation whereby Curateq Biologics Private Limited, a 100% subsidiary of the Company, agreed with MSD to extend the timelines of LOI till 31st May 2024.28-03-2024
AUROBINDO PHARMA LTD. - 524804 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Trustee Services Ltd28-03-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of changes in Board of Directors of the Company27-03-2024
AUROBINDO PHARMA LTD. - 524804 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Submission of Scrutinizer Report on Postal Ballot conducted for appointment of Dr. Deepali Pant Joshi as an Independent Director of the Company.26-03-2024
AUROBINDO PHARMA LTD. - 524804 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Submission of outcome of Postal Ballot in connection with appointment of Dr. Deepali Pant Joshi as an Independent Director of the Company26-03-2024
AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window
Intimation of closure of Trading Window from 1st April 2024 till 48 hours after the declaration of the Audited Financial Results of the Company for the year ended 31st March 2024.26-03-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of notices published in news papers20-03-2024